3PC-029 Study of PSMA11-68Ga adsorption on medical devices used for radiosynthesis and media fill test

Background and importancePSMA-11 labelled with gallium-68 (PSMA11-68Ga) is a diagnostic radiopharmaceutical. Labelling is performed in a Trasis Mini all-in-one synthesiser. Sterile excipients, solvents and devices are necessary to produce a sterile and pyrogen-free injectable solution.Aim and object...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of hospital pharmacy. Science and practice 2022-03, Vol.29 (Suppl 1), p.A25-A25
Hauptverfasser: Durieux, F, Dekyndt, B, Legrand, JF, Semah, F
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page A25
container_issue Suppl 1
container_start_page A25
container_title European journal of hospital pharmacy. Science and practice
container_volume 29
creator Durieux, F
Dekyndt, B
Legrand, JF
Semah, F
description Background and importancePSMA-11 labelled with gallium-68 (PSMA11-68Ga) is a diagnostic radiopharmaceutical. Labelling is performed in a Trasis Mini all-in-one synthesiser. Sterile excipients, solvents and devices are necessary to produce a sterile and pyrogen-free injectable solution.Aim and objectivesThe aim of this study was device evaluation. Two aspects were investigated: the sterility of the final preparation and the absorption of PSMA11-68Ga on the device.Material and methodsDevice adsorption evaluation: radioactivity was measured with an ISOMED 2010 activity meter. PSMA11-68Ga labelling was performed and five syringes of 5 mL were filled with 1 mL from the preparation vial every 30 min after the end of the preparation. The weight activity (MBq/mg) of the preparation vial and syringes was calculated, measuring the activity and weight of each of them. At the end of the labelling process, the PSMA11-Ga68 preparation was totally filled in the preparation vial. The residual activity of different parts of the device were measured: the elution vial, the five syringes, the extraction cartridge, the synthesiser garbage, the vented filter, and three additional syringes were measured after three rinses with sodium chloride within 1 hour to 5 hours after elution. Finally, the activity of the elution vial at the end of the elution step and the activity of the final preparation vial at the end of the labelling process were compared on nine syntheses.Final preparation sterility: media fill tests (MFT) were performed on three syntheses, replacing the excipients and solvents with tryptone-casein-soybean solution. A fertility test was performed with concentrated bacterial strains in accordance with the European Pharmacopoeia.ResultsThe weight activity difference between the final preparation vial and the five syringes were between 4% and 7%. Residual activities in the syringes, the vented filter, the waste garbage, the extraction cartridge and the three additional syringes were between 0.2% and 5% of the elution activity. The activity variation between the elution and final preparation vials were between –4% and +5%. The MFT did not show microbiological contamination after 14 days of incubation at 37°C. The fertility test was positive after 24 hours of incubation.Conclusion and relevanceThese results show that the adsorption of PSMA11-68Ga on medical devices used for synthesis appeared to be limited. The MFT performed show that the manufacturing process was aseptic.
doi_str_mv 10.1136/ejhpharm-2022-eahp.52
format Article
fullrecord <record><control><sourceid>proquest_bmj_j</sourceid><recordid>TN_cdi_proquest_journals_2672351896</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2672351896</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1172-72cd51bcf0651f65df7e48c5567c20a9569f315a2477d81f1ee386ab1d76fe823</originalsourceid><addsrcrecordid>eNpFkF1LwzAUhoMoOOZ-ghDwOjMnaT56OYZOYaIwvS5pk9COrqlNK-zOG_-ov8TO-QEHzrl4eF_Og9Al0DkAl9duW7al6XaEUcaIM2U7F-wETRhNFElTmZz-3UKeo1mMVU4F5zpNeDpBJX9aEsrSz_ePTT_YPQ4eP20eFgBE6pXBxsbQtX0VGjzOztmqMDW27q0qXMRDdBb70OHO2CrEfdOXLlYRm8Z-swb7qq5x72J_gc68qaOb_ewperm9eV7ekfXj6n65WJMcQDGiWGEF5IWnUoCXwnrlEl0IIVXBqBl_SD0HYViilNXgwTmupcnBKumdZnyKro65bRdeh7E424aha8bKjEnFuACdypGCI5Xvtv8A0OzgNPt1mh2cZgenmWD8C-Y6bOo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2672351896</pqid></control><display><type>article</type><title>3PC-029 Study of PSMA11-68Ga adsorption on medical devices used for radiosynthesis and media fill test</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Durieux, F ; Dekyndt, B ; Legrand, JF ; Semah, F</creator><creatorcontrib>Durieux, F ; Dekyndt, B ; Legrand, JF ; Semah, F</creatorcontrib><description>Background and importancePSMA-11 labelled with gallium-68 (PSMA11-68Ga) is a diagnostic radiopharmaceutical. Labelling is performed in a Trasis Mini all-in-one synthesiser. Sterile excipients, solvents and devices are necessary to produce a sterile and pyrogen-free injectable solution.Aim and objectivesThe aim of this study was device evaluation. Two aspects were investigated: the sterility of the final preparation and the absorption of PSMA11-68Ga on the device.Material and methodsDevice adsorption evaluation: radioactivity was measured with an ISOMED 2010 activity meter. PSMA11-68Ga labelling was performed and five syringes of 5 mL were filled with 1 mL from the preparation vial every 30 min after the end of the preparation. The weight activity (MBq/mg) of the preparation vial and syringes was calculated, measuring the activity and weight of each of them. At the end of the labelling process, the PSMA11-Ga68 preparation was totally filled in the preparation vial. The residual activity of different parts of the device were measured: the elution vial, the five syringes, the extraction cartridge, the synthesiser garbage, the vented filter, and three additional syringes were measured after three rinses with sodium chloride within 1 hour to 5 hours after elution. Finally, the activity of the elution vial at the end of the elution step and the activity of the final preparation vial at the end of the labelling process were compared on nine syntheses.Final preparation sterility: media fill tests (MFT) were performed on three syntheses, replacing the excipients and solvents with tryptone-casein-soybean solution. A fertility test was performed with concentrated bacterial strains in accordance with the European Pharmacopoeia.ResultsThe weight activity difference between the final preparation vial and the five syringes were between 4% and 7%. Residual activities in the syringes, the vented filter, the waste garbage, the extraction cartridge and the three additional syringes were between 0.2% and 5% of the elution activity. The activity variation between the elution and final preparation vials were between –4% and +5%. The MFT did not show microbiological contamination after 14 days of incubation at 37°C. The fertility test was positive after 24 hours of incubation.Conclusion and relevanceThese results show that the adsorption of PSMA11-68Ga on medical devices used for synthesis appeared to be limited. The MFT performed show that the manufacturing process was aseptic.References and/or acknowledgementsConflict of interestNo conflict of interest</description><identifier>ISSN: 2047-9956</identifier><identifier>EISSN: 2047-9964</identifier><identifier>DOI: 10.1136/ejhpharm-2022-eahp.52</identifier><language>eng</language><publisher>London: British Medical Journal Publishing Group</publisher><subject>Adsorption ; Conflicts of interest ; Fertility ; Labeling ; Medical equipment ; Section 3: Production and compounding</subject><ispartof>European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A25-A25</ispartof><rights>European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2022 European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Durieux, F</creatorcontrib><creatorcontrib>Dekyndt, B</creatorcontrib><creatorcontrib>Legrand, JF</creatorcontrib><creatorcontrib>Semah, F</creatorcontrib><title>3PC-029 Study of PSMA11-68Ga adsorption on medical devices used for radiosynthesis and media fill test</title><title>European journal of hospital pharmacy. Science and practice</title><addtitle>Eur J Hosp Pharm</addtitle><description>Background and importancePSMA-11 labelled with gallium-68 (PSMA11-68Ga) is a diagnostic radiopharmaceutical. Labelling is performed in a Trasis Mini all-in-one synthesiser. Sterile excipients, solvents and devices are necessary to produce a sterile and pyrogen-free injectable solution.Aim and objectivesThe aim of this study was device evaluation. Two aspects were investigated: the sterility of the final preparation and the absorption of PSMA11-68Ga on the device.Material and methodsDevice adsorption evaluation: radioactivity was measured with an ISOMED 2010 activity meter. PSMA11-68Ga labelling was performed and five syringes of 5 mL were filled with 1 mL from the preparation vial every 30 min after the end of the preparation. The weight activity (MBq/mg) of the preparation vial and syringes was calculated, measuring the activity and weight of each of them. At the end of the labelling process, the PSMA11-Ga68 preparation was totally filled in the preparation vial. The residual activity of different parts of the device were measured: the elution vial, the five syringes, the extraction cartridge, the synthesiser garbage, the vented filter, and three additional syringes were measured after three rinses with sodium chloride within 1 hour to 5 hours after elution. Finally, the activity of the elution vial at the end of the elution step and the activity of the final preparation vial at the end of the labelling process were compared on nine syntheses.Final preparation sterility: media fill tests (MFT) were performed on three syntheses, replacing the excipients and solvents with tryptone-casein-soybean solution. A fertility test was performed with concentrated bacterial strains in accordance with the European Pharmacopoeia.ResultsThe weight activity difference between the final preparation vial and the five syringes were between 4% and 7%. Residual activities in the syringes, the vented filter, the waste garbage, the extraction cartridge and the three additional syringes were between 0.2% and 5% of the elution activity. The activity variation between the elution and final preparation vials were between –4% and +5%. The MFT did not show microbiological contamination after 14 days of incubation at 37°C. The fertility test was positive after 24 hours of incubation.Conclusion and relevanceThese results show that the adsorption of PSMA11-68Ga on medical devices used for synthesis appeared to be limited. The MFT performed show that the manufacturing process was aseptic.References and/or acknowledgementsConflict of interestNo conflict of interest</description><subject>Adsorption</subject><subject>Conflicts of interest</subject><subject>Fertility</subject><subject>Labeling</subject><subject>Medical equipment</subject><subject>Section 3: Production and compounding</subject><issn>2047-9956</issn><issn>2047-9964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpFkF1LwzAUhoMoOOZ-ghDwOjMnaT56OYZOYaIwvS5pk9COrqlNK-zOG_-ov8TO-QEHzrl4eF_Og9Al0DkAl9duW7al6XaEUcaIM2U7F-wETRhNFElTmZz-3UKeo1mMVU4F5zpNeDpBJX9aEsrSz_ePTT_YPQ4eP20eFgBE6pXBxsbQtX0VGjzOztmqMDW27q0qXMRDdBb70OHO2CrEfdOXLlYRm8Z-swb7qq5x72J_gc68qaOb_ewperm9eV7ekfXj6n65WJMcQDGiWGEF5IWnUoCXwnrlEl0IIVXBqBl_SD0HYViilNXgwTmupcnBKumdZnyKro65bRdeh7E424aha8bKjEnFuACdypGCI5Xvtv8A0OzgNPt1mh2cZgenmWD8C-Y6bOo</recordid><startdate>20220323</startdate><enddate>20220323</enddate><creator>Durieux, F</creator><creator>Dekyndt, B</creator><creator>Legrand, JF</creator><creator>Semah, F</creator><general>British Medical Journal Publishing Group</general><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20220323</creationdate><title>3PC-029 Study of PSMA11-68Ga adsorption on medical devices used for radiosynthesis and media fill test</title><author>Durieux, F ; Dekyndt, B ; Legrand, JF ; Semah, F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1172-72cd51bcf0651f65df7e48c5567c20a9569f315a2477d81f1ee386ab1d76fe823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adsorption</topic><topic>Conflicts of interest</topic><topic>Fertility</topic><topic>Labeling</topic><topic>Medical equipment</topic><topic>Section 3: Production and compounding</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Durieux, F</creatorcontrib><creatorcontrib>Dekyndt, B</creatorcontrib><creatorcontrib>Legrand, JF</creatorcontrib><creatorcontrib>Semah, F</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>European journal of hospital pharmacy. Science and practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Durieux, F</au><au>Dekyndt, B</au><au>Legrand, JF</au><au>Semah, F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>3PC-029 Study of PSMA11-68Ga adsorption on medical devices used for radiosynthesis and media fill test</atitle><jtitle>European journal of hospital pharmacy. Science and practice</jtitle><stitle>Eur J Hosp Pharm</stitle><date>2022-03-23</date><risdate>2022</risdate><volume>29</volume><issue>Suppl 1</issue><spage>A25</spage><epage>A25</epage><pages>A25-A25</pages><issn>2047-9956</issn><eissn>2047-9964</eissn><abstract>Background and importancePSMA-11 labelled with gallium-68 (PSMA11-68Ga) is a diagnostic radiopharmaceutical. Labelling is performed in a Trasis Mini all-in-one synthesiser. Sterile excipients, solvents and devices are necessary to produce a sterile and pyrogen-free injectable solution.Aim and objectivesThe aim of this study was device evaluation. Two aspects were investigated: the sterility of the final preparation and the absorption of PSMA11-68Ga on the device.Material and methodsDevice adsorption evaluation: radioactivity was measured with an ISOMED 2010 activity meter. PSMA11-68Ga labelling was performed and five syringes of 5 mL were filled with 1 mL from the preparation vial every 30 min after the end of the preparation. The weight activity (MBq/mg) of the preparation vial and syringes was calculated, measuring the activity and weight of each of them. At the end of the labelling process, the PSMA11-Ga68 preparation was totally filled in the preparation vial. The residual activity of different parts of the device were measured: the elution vial, the five syringes, the extraction cartridge, the synthesiser garbage, the vented filter, and three additional syringes were measured after three rinses with sodium chloride within 1 hour to 5 hours after elution. Finally, the activity of the elution vial at the end of the elution step and the activity of the final preparation vial at the end of the labelling process were compared on nine syntheses.Final preparation sterility: media fill tests (MFT) were performed on three syntheses, replacing the excipients and solvents with tryptone-casein-soybean solution. A fertility test was performed with concentrated bacterial strains in accordance with the European Pharmacopoeia.ResultsThe weight activity difference between the final preparation vial and the five syringes were between 4% and 7%. Residual activities in the syringes, the vented filter, the waste garbage, the extraction cartridge and the three additional syringes were between 0.2% and 5% of the elution activity. The activity variation between the elution and final preparation vials were between –4% and +5%. The MFT did not show microbiological contamination after 14 days of incubation at 37°C. The fertility test was positive after 24 hours of incubation.Conclusion and relevanceThese results show that the adsorption of PSMA11-68Ga on medical devices used for synthesis appeared to be limited. The MFT performed show that the manufacturing process was aseptic.References and/or acknowledgementsConflict of interestNo conflict of interest</abstract><cop>London</cop><pub>British Medical Journal Publishing Group</pub><doi>10.1136/ejhpharm-2022-eahp.52</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2047-9956
ispartof European journal of hospital pharmacy. Science and practice, 2022-03, Vol.29 (Suppl 1), p.A25-A25
issn 2047-9956
2047-9964
language eng
recordid cdi_proquest_journals_2672351896
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Adsorption
Conflicts of interest
Fertility
Labeling
Medical equipment
Section 3: Production and compounding
title 3PC-029 Study of PSMA11-68Ga adsorption on medical devices used for radiosynthesis and media fill test
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T12%3A11%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_j&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=3PC-029%E2%80%85Study%20of%20PSMA11-68Ga%20adsorption%20on%20medical%20devices%20used%20for%20radiosynthesis%20and%20media%20fill%20test&rft.jtitle=European%20journal%20of%20hospital%20pharmacy.%20Science%20and%20practice&rft.au=Durieux,%20F&rft.date=2022-03-23&rft.volume=29&rft.issue=Suppl%201&rft.spage=A25&rft.epage=A25&rft.pages=A25-A25&rft.issn=2047-9956&rft.eissn=2047-9964&rft_id=info:doi/10.1136/ejhpharm-2022-eahp.52&rft_dat=%3Cproquest_bmj_j%3E2672351896%3C/proquest_bmj_j%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2672351896&rft_id=info:pmid/&rfr_iscdi=true